Article
High-resolution melting effectively pre-screens for TP53 mutations before direct sequencing in patients with diffuse glioma.
Human cell - 1 Mar 2021
Saito Kiyotaka, Yokogami Kiyotaka, Maekawa Kazunari, Sato Yuichiro, Yamashita Shinji, Matsumoto Fumitaka, Mizuguchi Asako, Takeshima Hideo
Abstract excerpt
TP53 mutations are important molecular markers in diffuse astrocytic tumors and medulloblastomas. We examined the efficacy of a pre-screening method for high-resolution melting (HRM) analysis of TP53 mutation before direct sequencing using samples from patients with diffuse glioma. Surgical samples from 64 diffuse gliomas were classified based on the 2016 World Health Organization (WHO) histopathological grading...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
